Use the REVEAL Lite 2 Risk Score Calculator to quickly calculate your patient's risk score and to help determine whether treatment escalation may be needed ...
These online risk calculators can help you quickly calculate your patient's risk score with point-and-click ease. You can choose from among 5 calculators— ...
People also ask
What is the reveal Lite 2 methodology?
What is the prognosis for pulmonary hypertension?
What are the risk scores for PAH?
What is the simplified French risk score?
REVEAL Lite 2 is a robust tool that provides discrimination among patients at low, intermediate, and high risk of 1-year mortality. Trial registry: ...
Feb 3, 2021 · “Risk calculators that assess fewer and noninvasive variables without compromising discrimination and accuracy may help both expedite and ...
Based on the patients' REVEAL Lite 2.0 score, in the “no event” group, 63 (71.6%) were low risk (Score 1–5), 18 (20.5%) were intermediate risk (Score 6–7) and 7 ...
REVEAL Lite 2 is a multiparameter risk assessment tool for patients with PAH that provides a simplified and robust risk calculator for routine clinical ...
[PDF] Using REVEAL 2.0 and REVEAL Lite 2 for regular risk assessment
www.pahriskassessment.com › pdfs
Use the REVEAL 2.0 and REVEAL Lite 2 risk score calculators below to assess your patients and track their risk factors. Fill in response for each determinant.
REVEAL Lite 2 risk strata were based on REVEAL 2.0 risk scores using a subpopulation of patients in REVEAL who had survived for ≥1 year after enrollment.12 ...
REVEAL Lite 2: A simplified and robust calculator that closely approximates REVEAL 2.0 at discriminating risk. 6 PARAMETERS.
Oct 28, 2021 · Results. REVEAL Lite 2 score improved with riociguat 2.5 mg at PATENT-1 Week 12 (least-squares mean difference vs placebo: –0.8; p = 0.0004).